UK Approves โ€˜Game-changingโ€™ Drug For Advanced Breast Cancer Treatment

The United Kingdomโ€™s National Institute for Health and Care Excellence (NICE) has approved a โ€œgame-changingโ€ twice-daily pill that is said to slow the spread of an incurable type of breast cancer. The drug, Truqap, developed by AstraZeneca, targets the AKT protein, a molecule known to fuel the multiplication of cancer cells. By inhibiting AKTโ€™s action,…

Read More
Go Up